Recall of Viracept (Nelfinavir) (New Zealand)
This article was originally published in PharmAsia News
Executive Summary
New Zealand pharmaceutical regulator PHARMAC has issued a recall for Roche's anti-HIV drug Viracept because of concern that some batches of the drug may have been contaminated. Roche itself has issued a worldwide voluntary recall of Viracept. About 20 people in New Zealand have prescriptions for Viracept. (Click here for more